Form D · Pharmaceuticals

Venatorx Pharmaceuticals, Inc.

Malvern, PA · CIK 0001590501

Offering snapshot reported Jul 13, 2023 · SEC filing

Reported sold
$35M
Offering amount: $48.2M
Investors reported
3
Form D · investor count
Minimum accepted
$0
Reported outside-investor minimum
First sale
Feb 17, 2023
As reported in this filing

Fundraising history

Reported sold
Reported amount sold by Form D filing date$0$17.5M$35MFeb 27, 2023: $15,000,000.00Feb 27, 2023Jul 13, 2023: $35,008,357.00Jul 13, 2023

Dates are filing dates, not cash receipt dates. Decreases are reported revisions, not evidence of withdrawals. Separate offering histories are not added together.

What changed?

Latest filing versus its linked predecessor, where available.

  • Reported sold$15,000,000 → $35,008,357
  • Reported investors2 → 3

Filing history

Scroll to see all columns →

FiledFiling typeReported soldChange vs linked filingInvestorsSource
Jul 13, 2023Amendment$35,008,357$20,008,357vs Feb 27, 20233SEC filing
Feb 27, 2023Initial$15,000,000No comparison2SEC filing
Dec 22, 2022Amendment$24,700,001$11,999,999vs Sep 2, 20222SEC filing
Sep 2, 2022Initial$12,700,002No comparison2SEC filing
Apr 4, 2022Initial$34,000,000No comparison3SEC filing
Nov 5, 2018Amendment$27,127,661$5,227,594vs Jul 25, 201747SEC filing
Jul 25, 2017Initial$21,900,067No comparison42SEC filing
Dec 4, 2013Initial$3,419,051No comparison59SEC filing

Offering details

Securities
Debt, Option to acquire, Security to be acquired
Exemptions
06b
Duration over one year
No
Business combination
No
Sales commissions
$0
Finders' fees
$0
Form D file number
021-474330

Source: Form D, filed Jul 13, 2023. Minimum accepted may differ from a standard advertised minimum.

Fund connections

No confirmed ADV fund connection is available for this issuer.

People & organizations

Current and past Form D appearances. These existing records do not establish a person's current role or uniquely identify them across issuers.

People and organizations reported in Form D filings
NameReported role
Christopher J Burns Director, Executive
Shelley Chu Director
Michael Diem Director
Ezra Felker Executive
Timothy Haines Director
Martin Heidecker Director
Timothy J. Henkel Executive
Tim Henkel Executive
Tomas Heyman Director
Anthony Meehan Executive
Vincent J. Milano Director
James Murphy Executive
Sergei Petukhov Director
Daniel C Pevear Executive
Carlo Rizzuto Director
Luigi Xerri Executive

Issuer details

Industry: Pharmaceuticals (See others in industry)

Address:
30 Spring Mill Drive
Malvern, PA, 19355